Loading...
XJPX
9627
Market cap1.38bUSD
Jul 16, Last price  
5,805.00JPY
1D
0.57%
1Q
11.76%
Jan 2017
-25.00%
Name

AIN Holdings Inc

Chart & Performance

D1W1MN
P/E
17.86
P/S
0.51
EPS
325.06
Div Yield, %
1.38%
Shrs. gr., 5y
-0.17%
Rev. gr., 5y
7.73%
Revenues
399.82b
+11.45%
76,303,722,00081,307,353,000106,231,989,000115,387,067,000125,495,820,000129,387,173,000142,790,684,000154,560,620,000170,225,754,000187,904,956,000234,843,598,000248,110,130,000268,385,718,000275,596,000,000292,615,000,000297,305,000,000316,247,000,000358,742,000,000399,824,000,000
Net income
11.40b
+23.47%
1,215,782,0001,010,536,0001,615,983,0002,127,901,0003,131,216,0003,916,991,0004,899,402,0005,075,114,0005,259,398,0006,197,170,0007,917,117,0007,949,399,00010,567,415,0009,029,000,0009,179,000,0006,697,000,0007,092,000,0009,234,000,00011,401,000,000
CFO
23.02b
+13.60%
3,623,315,0002,277,837,0008,424,432,0004,333,422,0006,428,462,0007,627,098,00011,679,656,00010,203,704,00014,662,829,00014,839,948,00021,352,361,00018,409,088,00021,656,606,00014,788,000,00017,747,000,00014,928,000,00026,156,000,00020,267,000,00023,023,000,000
Dividend
Apr 28, 20250 JPY/sh
Earnings
Sep 02, 2025

Profile

Ain Holdings Inc. engages in the dispensing pharmacy, and cosmetic and drug store businesses in Japan. The company's Dispensing Pharmacy segment operates dispensing pharmacies; sells generic drugs; and provides staff dispatching and introduction services, as well as consulting services. Its Cosmetic and Drug Store segment engages in the management of cosmetic and drug stores under the AINZ & TULPE brand name. The company's Other segment is involved in the retail store and real estate rental activities. As of April 30, 2021, it operated 1,065 dispensing pharmacies; and 69 cosmetic and drug stores. The company was formerly known as Ain Pharmaciez Inc. and changed its name to Ain Holdings Inc. in November 2015. Ain Holdings Inc. was incorporated in 1969 and is headquartered in Sapporo, Japan.
URL
https://www.ainj.co.jp/
IPO date
Mar 18, 1994
Employees
10,561
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑042023‑042022‑042021‑042020‑042019‑042018‑042017‑042016‑04
Income
Revenues
399,824,000
11.45%
358,742,000
13.44%
Cost of revenue
370,768,000
308,601,000
Unusual Expense (Income)
NOPBT
29,056,000
50,141,000
NOPBT Margin
7.27%
13.98%
Operating Taxes
7,670,000
6,638,000
Tax Rate
26.40%
13.24%
NOPAT
21,386,000
43,503,000
Net income
11,401,000
23.47%
9,234,000
30.20%
Dividends
(2,107,000)
(1,932,000)
Dividend yield
1.00%
0.98%
Proceeds from repurchase of equity
(821,000)
BB yield
0.39%
Debt
Debt current
3,467,000
3,670,000
Long-term debt
3,303,000
5,085,000
Deferred revenue
Other long-term liabilities
7,501,000
7,165,000
Net debt
(45,635,000)
(72,988,000)
Cash flow
Cash from operating activities
23,023,000
20,267,000
CAPEX
(9,130,000)
(12,155,000)
Cash from investing activities
(15,748,000)
(22,292,000)
Cash from financing activities
(5,110,000)
(11,237,000)
FCF
41,901,000
32,958,000
Balance
Cash
48,611,000
46,796,000
Long term investments
3,794,000
34,947,000
Excess cash
32,413,800
63,805,900
Stockholders' equity
117,255,000
234,401,000
Invested Capital
117,230,200
75,202,100
ROIC
22.23%
69.17%
ROCE
19.42%
36.05%
EV
Common stock shares outstanding
35,120
35,129
Price
5,970.00
5.85%
5,640.00
-3.42%
Market cap
209,667,200
5.82%
198,128,214
-3.63%
EV
164,136,200
251,596,214
EBITDA
39,941,000
59,980,000
EV/EBITDA
4.11
4.19
Interest
39,000
52,000
Interest/NOPBT
0.13%
0.10%